The study determines the EPA DHA uptake from different omega-3 supplements against a control.
The chronic uptake of omega-3 fatty acids EPA and DHA are commonly determined by measurement of EPA and DHA in red bloods cells and presented as a % of total fatty acids, the so-called Omega-3 Index. The index is a validated risk assessment for cardiovascular disease. Different fish oils may influence the Omega-3 Index differently depending on their composition. This study assesses omega-3 commonly found as a supplement vs a fish oil based on north atlantic fish species.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
56
Møreforsking AS
Ålesund, Norway
RECRUITINGChange in Omega-3 index
Change in the omega-3 index (EPA and DHA content as a % of total fatty acids in red blood cells) from baseline to end of supplementation
Time frame: Baseline (supplementation start: time point 0) to 2 months of supplementation
Change in fatty acid profile from baseline to end of supplementation between study arms.
The secondary endpoint measures the fatty acid profiles from baseline to end of supplementation for each study arm. The results will then be compared between groups. Fatty acid profiles will be analyzed on whole blood samples using the Omega-quant test kit and analysis service. Changes in the analyzed fatty acids are determined from statistical assessment of whole blood analysis. The fatty acid profile is an exploratory endpoint.
Time frame: Baseline to 2 months of supplementation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.